Pavel Brezina, who led the establishment of Gilead’s affiliate in the Czech Republic and Slovakia seven years ago, shares the amazing journey of bringing the company’s life-saving treatments for HIV infection and chronic hepatitis C (CHC) to patients and presents the way the affiliate collaborates with authorities and associations to put an end to both epidemics. Pavel also recounts the preparations he and his team have made to introduce CAR-T therapy to Czech patients and discusses the coming changes in market access for orphan drugs.
In the Czech Republic, all HIV-positive patients can be immediately treated after diagnosis, which is key to stopping the epidemic.
